Bill & Melinda Gates Foundation
P.O. Box 23350
Seattle
Washington
98102
United States
Tel: 206-709-3100
Website: http://www.gatesfoundation.org/
Email: info@gatesfoundation.org
200 articles with Bill & Melinda Gates Foundation
-
Children's Hospital of Philadelphia Receives Grant to Propel Critical Research in the Mitochondrial Space
2/8/2023
To advance vital mitochondrial medicine research and help decode the pandemic puzzle, Children's Hospital of Philadelphia has received more than $2.3 million from the Bill & Melinda Gates Foundation.
-
MIP Discovery Secures Significant Funding to Support Development of Global Rapid Response Diagnostics
2/1/2023
MIP Discovery, a leader in rationally designed detection reagents based on its proprietary nanoMIP™ technology, has announced it has secured a significant grant of funds from the Bill & Melinda Gates Foundation.
-
VisualDx Awarded Grant to Advance Global Health and Diagnostic Accuracy in Underserved Regions
1/18/2023
VisualDx, an award-winning web-based clinical decision support system, has received a grant from the Bill & Melinda Gates Foundation to develop diagnostic and surveillance tools to help medical providers improve treatment decisions and outcomes in underserved areas.
-
Sherlock Biosciences Receives Grant to Advance Development of Power-free Diagnostics
11/29/2022
Sherlock Biosciences today announced that it has received additional funding from the Bill & Melinda Gates Foundation to advance its rapid, instrument-free molecular diagnostic testing platform.
-
Cyclica receives CAD$2.4M grant for a multi-targeted drug discovery program to advance non-hormonal contraceptive medicines
11/15/2022
Cyclica receives a grant from the Bill & Melinda Gates Foundation to apply its AI-enabled drug discovery platform to discover new therapeutic options for multiple low-data biological targets with the goal of expanding the range of accessible non-hormonal contraceptive choices for women in developing countries.
-
Daré Bioscience Announces Grant to Develop Novel Hydrogel Formulation for Delivery of Live Biotherapeutics to Support Vaginal Health
11/15/2022
Daré Bioscience, Inc. today announced it has received a grant from the Bill & Melinda Gates Foundation (the foundation) of $584,986 to support activities related to development of a vaginal thermosetting gel formulation for the delivery of live biotherapeutics that can be reconstituted at the point of care.
-
Bill & Melinda Gates Foundation Announces Additional Support to Promote Locally Led R&D; Calls for Proposals
10/24/2022
The Bill & Melinda Gates Foundation announced a series of initiatives and a call for proposals to advance locally-led innovation that supports work by scientists and researchers in developing economies.
-
Adapsyn Bioscience receives funding to discover novel therapeutics for tuberculosis
10/18/2022
Adapsyn Bioscience Inc. today announced that it has received funding from the Bill & Melinda Gates Foundation to find novel therapeutics that target tuberculosis (TB).
-
With New Commitment, Gates Foundation Joins Call to Help End Polio
10/16/2022
At the World Health Summit, the Bill & Melinda Gates Foundation announced it will commit $1.2 billion to support efforts to end all forms of polio globally.
-
Gates Foundation Announces $1.27 Billion in Health and Development Commitments to Advance Progress Toward the Global Goals
9/21/2022
During United Nations General Assembly week, the Bill & Melinda Gates Foundation announced commitments totalling $1.27 billion to improve and save millions of lives.
-
Celanese Announces Grant Award to Develop Long-Acting, Refillable Drug Delivery Solution
8/24/2022
Celanese Corporation, a global chemical and specialty materials company, announced receipt of a grant from the Bill & Melinda Gates Foundation to produce and characterize a working prototype for a refillable contraceptive implant.
-
The Bill & Melinda Gates Foundation inked a memorandum of understanding with South Korea’s foreign and health ministries to expand their partnerships revolving around public health.
-
CaliberMRI, Inc. Announces Award to Improve Pediatric Brain Imaging at More than 25 Sites Around the World
8/10/2022
CaliberMRI, an industry leader in standardization of Magnetic Resonance Imaging, has been awarded a grant from the Bill & Melinda Gates Foundation to improve repeatability and reproducibility of diagnostic imaging for neonatal and pediatric brain development of children in Africa and Southeast Asia.
-
Sapient Receives $9.2M Grant for Population-Scale Discovery Mass Spectrometry Analysis
7/11/2022
The grant from Bill & Melinda Gates Foundation will support studies to identify biomarkers that can inform novel nutritional, disease-prevention, and disease-treatment interventions.
-
Conagen’s Grant Award Opens New Markets for Monoclonal Antibodies
3/29/2022
The Bill & Melinda Gates Foundation has given a grant to Conagen to support further development of its Conamax platform for the production of accessible low-cost and high-quality monoclonal antibodies, benefitting developing countries and patients globally.
-
Bill & Melinda Gates Foundation and Wellcome Pledge US$300 Million to CEPI for COVID-19 Pandemic Response and to Accelerate Epidemic Preparedness
1/18/2022
The Bill & Melinda Gates Foundation and Wellcome each pledged US$150 million for a total of US$300 million to the Coalition for Epidemic Preparedness Innovations, a global partnership launched five years ago this week by the governments of Norway and India, the Gates Foundation, Wellcome, and the World Economic Forum.
-
Emergent BioSolutions, Vir Biotechnology and Thermo Fisher, come into 2022 with reports of new opportunities, new vaccines, and partnership expansions.
-
IGM Biosciences to Collaborate on the Study of IgM and IgA Antibodies for the Prevention of Malaria
12/8/2021
IGM Biosciences, Inc. today announced a grant agreement with the Bill & Melinda Gates Foundation to fund the design, production, and evaluation of IgM and IgA antibodies for the potential prevention of malaria.
-
Providence Therapeutics announces $2.118 Million USD in funding to support process development and validation of the PTX-COVID19-B program
12/7/2021
Providence Therapeutics announced today that their COVID-19 vaccine program, PTX-COVID19-B, has received $2.118 Million USD in funding from the Bill & Melinda Gates Foundation.
-
Schrödinger Awarded Grant to Accelerate Drug Discovery in Women’s Health
11/18/2021
Schrödinger will receive $4.9 million research grant from the Bill & Melinda Gates Foundation to support early-stage drug discovery of non-hormonal contraceptives.